Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Cescon

Showing results (1-10 of 133) with videos related to

Pageof 14
Sort By:
The Lancet. Oncology|March 7, 2021
Pembrolizumab monotherapy in metastatic triple-negative breast cancerEitan Amir, David W Cescon
JAMA|May 15, 2008
Barcoded medication administration: a last line of defenseDavid W Cescon, Edward Etchells
JNCI Cancer Spectrum|July 31, 2019
Gene Expression Analyses in Breast Cancer: Sample MattersBenjamin Haibe-Kains, David W Cescon
International Journal of Molecular Sciences|November 13, 2025
Navigating Treatment Sequencing in Advanced HR+/HER2- Breast Cancer After CDK4/6 Inhibitors: Biomarker-Driven Strategies and Emerging TherapiesDana P Narvaez, David W Cescon
Current Opinion in Oncology|September 23, 2021
Accelerating drug access from advanced to early breast cancer: the special case of oral selective estrogen receptor degradersBrooke E Wilson, David W Cescon
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 21, 2009
Discoloration of skin and urine after treatment with hydroxocobalamin for cyanide poisoningDavid W Cescon, David N Juurlink
Genome Biology|October 8, 2016
DNA replication stress: a source of APOBEC3B expression in breast cancerDavid W Cescon, Benjamin Haibe-Kains
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2015
PIK3CA genotype and treatment decisions in human epidermal growth factor receptor 2-positive breast cancerDavid W Cescon, Philippe L Bedard
Breast (Edinburgh, Scotland)|December 14, 2021
Development of novel agents for the treatment of early estrogen receptor positive breast cancerMitchell J Elliott, David W Cescon
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2020
On the Road to Precision: Understanding the Biology Driving Genomic AssaysKevin Kalinsky, Alexandra Thomas, David W Cescon
Pageof 14

Showing results (1-10 of 133) with videos related to

Sort By:
Pageof 14
The Lancet. Oncology|March 7, 2021
Pembrolizumab monotherapy in metastatic triple-negative breast cancerEitan Amir, David W Cescon
JAMA|May 15, 2008
Barcoded medication administration: a last line of defenseDavid W Cescon, Edward Etchells
JNCI Cancer Spectrum|July 31, 2019
Gene Expression Analyses in Breast Cancer: Sample MattersBenjamin Haibe-Kains, David W Cescon
International Journal of Molecular Sciences|November 13, 2025
Navigating Treatment Sequencing in Advanced HR+/HER2- Breast Cancer After CDK4/6 Inhibitors: Biomarker-Driven Strategies and Emerging TherapiesDana P Narvaez, David W Cescon
Current Opinion in Oncology|September 23, 2021
Accelerating drug access from advanced to early breast cancer: the special case of oral selective estrogen receptor degradersBrooke E Wilson, David W Cescon
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 21, 2009
Discoloration of skin and urine after treatment with hydroxocobalamin for cyanide poisoningDavid W Cescon, David N Juurlink
Genome Biology|October 8, 2016
DNA replication stress: a source of APOBEC3B expression in breast cancerDavid W Cescon, Benjamin Haibe-Kains
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2015
PIK3CA genotype and treatment decisions in human epidermal growth factor receptor 2-positive breast cancerDavid W Cescon, Philippe L Bedard
Breast (Edinburgh, Scotland)|December 14, 2021
Development of novel agents for the treatment of early estrogen receptor positive breast cancerMitchell J Elliott, David W Cescon
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2020
On the Road to Precision: Understanding the Biology Driving Genomic AssaysKevin Kalinsky, Alexandra Thomas, David W Cescon
Pageof 14